Massive study tracks safety of new liver cancer treatments
NCT ID NCT05667064
Summary
This study monitored the safety of two already-approved drugs, IMJUDO and IMFINZI, in real-world patients with advanced liver cancer that cannot be removed by surgery. It involved 1200 patients in Japan to collect safety information after the drugs were made available to doctors. The goal was to better understand the side effects and safety profile of these treatments when used in regular medical practice.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.